Literature DB >> 17694369

Anti-uveitis and inhibition of fibroblast-like corneal and conjunctival cells by interleukin-1 blockers.

B Xuan1, G C Chiou.   

Abstract

Effects of interleukin-1 (IL-1) blockers, CK130 and CK131, on IL-1-induced uveitis and proliferation of fibroblast-like corneal and conjunctival cells were investigated in this study. It was found that CK130 and CK131 inhibited IL-1-induced uveitis in rat eyes effectively at 3 mg/kg and 10 mg/kg, respectively. Further, CK130 and CK131 inhibited fibroblast-like corneal and conjunctival cell growth effectively at 10-300 microg/ml and 30-300 microg/ml, respectively. It was also found that DNA synthesis was markedly reduced by CK130 and CK131 at 30-100 microg/ml. RNA synthesis was also inhibited by these CK compounds but protein synthesis was little affected or enhanced.

Entities:  

Year:  1998        PMID: 17694369     DOI: 10.1007/s10787-998-0029-x

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  10 in total

1.  Antagonism of interleukin-1 (IL-1)-induced uveitis with synthetic IL-1 blockers.

Authors:  G C Chiou; Z Chen; B Xuan; T Yamasaki; T Okawara
Journal:  J Ocul Pharmacol Ther       Date:  1997-10       Impact factor: 2.671

2.  Antiuveitis and inhibition of fibroblast-like corneal and conjunctival cell cultures by interleukin-1 blockers, CK 125, CK 126 and CK 128.

Authors:  B Xuan; G C Chiou; T Yamasaki; T Okawara
Journal:  Ophthalmic Res       Date:  1998       Impact factor: 2.892

3.  Inhibitory effects of interleukin-1 blockers on corneal fibroblast proliferation.

Authors:  Z Chen; S X Liu; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  1996       Impact factor: 2.671

4.  Effects of interleukin-1 blockers on ophthalmic wound healing in a rabbit model of trabeculectomy.

Authors:  N D Schwade; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

5.  Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124.

Authors:  B Xuan; G C Chiou; Z Chen; T Yamasaki; T Okawara
Journal:  J Ocul Pharmacol Ther       Date:  1998-02       Impact factor: 2.671

6.  Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents.

Authors:  G C Chiou; Q S Yao; M S Chang; T Okawara
Journal:  J Ocul Pharmacol       Date:  1994

7.  Interleukin-1 receptor antagonist production by human keratinocytes.

Authors:  C F Bigler; D A Norris; W L Weston; W P Arend
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

8.  Mechanisms of antagonism of interleukin-1 alpha by synthetic interleukin-1 blockers.

Authors:  J G Xiao; N Schwade; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

9.  Prevention of ocular inflammation induced by lens protein, endotoxin, and interleukin-1 with synthetic interleukin-1 blockers.

Authors:  G C Chiou; Q S Yao; T Okawara
Journal:  J Ocul Pharmacol       Date:  1994

10.  The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing.

Authors:  N D Schwade; G C Chiou
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.